These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30375863)

  • 1. Use of a Fluorescent Analogue of a HBV Core Protein-Directed Drug To Interrogate an Antiviral Mechanism.
    Nair S; Li L; Francis S; Turner WW; VanNieuwenhze M; Zlotnick A
    J Am Chem Soc; 2018 Nov; 140(45):15261-15269. PubMed ID: 30375863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.
    Ruan L; Hadden JA; Zlotnick A
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection.
    Ko C; Bester R; Zhou X; Xu Z; Blossey C; Sacherl J; Vondran FWR; Gao L; Protzer U
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.
    Viswanathan U; Mani N; Hu Z; Ban H; Du Y; Hu J; Chang J; Guo JT
    Antiviral Res; 2020 Oct; 182():104917. PubMed ID: 32818519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators.
    Luo Y; Cheng J; Hu Z; Ban H; Wu S; Hwang N; Kulp J; Li Y; Du Y; Chang J; Viswanathan U; Guo JT
    Antiviral Res; 2021 Jul; 191():105080. PubMed ID: 33933516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus Capsids Have Diverse Structural Responses to Small-Molecule Ligands Bound to the Heteroaryldihydropyrimidine Pocket.
    Venkatakrishnan B; Katen SP; Francis S; Chirapu S; Finn MG; Zlotnick A
    J Virol; 2016 Apr; 90(8):3994-4004. PubMed ID: 26842475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation.
    Zhao Q; Hu Z; Cheng J; Wu S; Luo Y; Chang J; Hu J; Guo JT
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors.
    Zhang X; Cheng J; Ma J; Hu Z; Wu S; Hwang N; Kulp J; Du Y; Guo JT; Chang J
    ACS Infect Dis; 2019 May; 5(5):759-768. PubMed ID: 30525438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro.
    Corcuera A; Stolle K; Hillmer S; Seitz S; Lee JY; Bartenschlager R; Birkmann A; Urban A
    Antiviral Res; 2018 Oct; 158():135-142. PubMed ID: 30031759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core Protein-Directed Antivirals and Importin β Can Synergistically Disrupt Hepatitis B Virus Capsids.
    Kim C; Barnes LF; Schlicksup CJ; Patterson AJ; Bothner B; Jarrold MF; Wang CJ; Zlotnick A
    J Virol; 2022 Jan; 96(2):e0139521. PubMed ID: 34705562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between Normative and Drug-Induced Virus Self-Assembly Observed with Single-Particle Methods.
    Kondylis P; Schlicksup CJ; Brunk NE; Zhou J; Zlotnick A; Jacobson SC
    J Am Chem Soc; 2019 Jan; 141(3):1251-1260. PubMed ID: 30537810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores.
    Huber AD; Pineda DL; Liu D; Boschert KN; Gres AT; Wolf JJ; Coonrod EM; Tang J; Laughlin TG; Yang Q; Puray-Chavez MN; Ji J; Singh K; Kirby KA; Wang Z; Sarafianos SG
    ACS Infect Dis; 2019 May; 5(5):750-758. PubMed ID: 30582687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Inhibition of Hepatitis B e Antigen by Core Protein Allosteric Modulator.
    Yan Z; Wu D; Hu H; Zeng J; Yu X; Xu Z; Zhou Z; Zhou X; Yang G; Young JAT; Gao L
    Hepatology; 2019 Jul; 70(1):11-24. PubMed ID: 30664279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
    Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids.
    Schlicksup CJ; Wang JC; Francis S; Venkatakrishnan B; Turner WW; VanNieuwenhze M; Zlotnick A
    Elife; 2018 Jan; 7():. PubMed ID: 29377794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging.
    Wu S; Luo Y; Viswanathan U; Kulp J; Cheng J; Hu Z; Xu Q; Zhou Y; Gong GZ; Chang J; Li Y; Guo JT
    Antiviral Res; 2018 Nov; 159():1-12. PubMed ID: 30201396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly.
    Stray SJ; Bourne CR; Punna S; Lewis WG; Finn MG; Zlotnick A
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8138-43. PubMed ID: 15928089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.